Results 221 to 230 of about 427,029 (392)

Chronic myeloid leukemia

HemaSphere, 2019
openaire   +3 more sources

[Corrigendum] ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling

, 2023
Yanhong Liu, Zhu Man, Panpan Lei, Xiaoyan Pan, Weina Ma   +4 more
openalex   +2 more sources

Artificial intelligence strategies for predicting kinase inhibitor resistance: A comprehensive review of methods, challenges, and future perspectives

Journal of Intelligent Medicine, EarlyView.
Abstract Kinase inhibitors are essential in targeted cancer therapy, yet resistance often emerges through secondary mutations, activation of compensatory signaling pathways, or drug‐efflux mechanisms. Artificial intelligence (AI) provides a workflow‐based strategy rather than a list of unrelated tools for predicting and addressing kinase‐inhibitor ...
Faris Hassan, Mohanad Ali Deifallah, Alaa Zaghloul, Rania Elgohary   +3 more
wiley   +1 more source

CHRONIC MYELOID LEUKEMIA

Nihon Naika Gakkai Zasshi, 1980
openaire   +3 more sources

Epigenetic inflammatory memory and periodontal disease: Mechanisms and clinical significance for comorbidities

Journal of Periodontology, EarlyView.
Abstract Historically, immunological memory was considered an exclusive feature of adaptive immunity. However, innate immune cells have recently been shown to record and maintain epigenetically imprinted memory of earlier infectious or inflammatory challenges.
George Hajishengallis
wiley   +1 more source

Behcet's disease in a patient with chronic myeloid leukemia. [PDF]

Indian J Sex Transm Dis AIDS
Singh D, Somasundaram A, Gajula AS, Kumar S.   +3 more
europepmc   +1 more source

Chronic myeloid leukemia with permanent disappearance of the Ph1 chromosome and development of new clonal subpopulations [PDF]

, 1979
A Hagemeijer, EM Smit, B Lowenberg, J. Abels   +3 more
openalex   +1 more source

Atypical Wounds in Chronic Graft‐Versus‐Host Disease and Peripheral Arterial Disease Caused by Tyrosine Kinase Inhibitors

JEADV Clinical Practice, EarlyView.
ABSTRACT The term “atypical wounds” primarily refers to lesions with immunological or cancerous etiologies. However, these wounds can also be drug‐induced. We report about a 32‐year‐old man with a 6‐year history of chronic myelogenous leukemia (CML) and chronic graft‐versus‐host disease (cGvHD) following an HLA‐compatible allogeneic stem cell ...
E. K. Stuermer, K. Malik, C. Willers, M. Augustin   +3 more
wiley   +1 more source

Atypical chronic myeloid leukemia: From diagnosis to molecular features and therapeutic options. [PDF]

Hemasphere
Iurlo A, Cattaneo D, Gianelli U, Passamonti F.   +3 more
europepmc   +1 more source

Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino, Cataldo Patruno, Francesca di Vico, Maddalena Napolitano   +3 more
wiley   +1 more source